Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Condition:   Breast Carcinoma Interventions:   Drug: Dexamethasone;   Other: Laboratory Biomarker Analysis;   Drug: Netupitant/Palonosetron Hydrochloride;   Drug: Olanzapine;   Other: Placebo;   Drug: Prochlorperazine;   Other: Quality-of-Life Assessment Sponsors:   Gary Morrow;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials